A study of the social stigma of the patients recieving DOTS under RNTCP in Munger district of Bihar, India  by Vishal, M. et al.
300 16th ICID Abstracts / International Journal of Infectious Diseases 21S (2014) 1–460
Type: Poster Presentation
Final Abstract Number: 56.003
Session: Tuberculosis and Other Mycobacterial Infections
Date: Friday, April 4, 2014
Time: 12:45-14:15
Room: Ballroom
A study of the social stigma of the patients
recieving DOTS under RNTCP in Munger district
of Bihar, India
M. Vishal, P. Rai, K. Sharma
Change Giver Mission, New Delhi, India
Background:Acceptance of DOTS stratergy in the Indian RNTCP
has certainlybrought encouraging success in themanagementof TB
caseswithin the country. However there are challenges to bemet in
the programme implementation, before the RNTCP objectives are
ﬁnally realized. One such challenge is the social stigma associated
with the TB patients. The study attempts to ﬁnd out the concerns of
the TB patients who receive the DOTS within the same community.
Objective:
Toknow themajor concerns of the TBpatientswhoare receiving
the DOTS from the DOTS providers within the same commu-
nity/village
Methods & Materials: An interview was conducted of 256
patients who are receiving the DOTS within their communi-
ties/villages across the ﬁve development blocks of Munger district
of Bihar
Results:Of all the TB patientswhowere interviewed 53 percent
reported that they wanted to hide from the community that they
have TB but they have to reveal it to others about their disease
because they have to take the DOTS from the providers within the
village. Of all those interviewed, 47 percent said that taking DOTS
hadanegative impact on themwith respect to social discrimination
within the community. 53 percent reported that because of DOTS
several people in the community knew that they have TBwhich led
to the discrimination.
Conclusion: Notions restricting the acceptance of TB patients
are still prevalent in the minds of people and require a propagation
of frequent IEC campaigns to remove superstitutions amongst the
people.
http://dx.doi.org/10.1016/j.ijid.2014.03.1042
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Associations between human leukocyte antigen
class I variants and the Mycobacterium
tuberculosis subtypes causing disease
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Background: The development of active tuberculosis disease
has been shown to be multifactorial. Interactions between host
and bacterial genotype may inﬂuence disease outcome, with some
studies indicating the adaptation of Mycobacterium tuberculosis
strains to speciﬁc human populations. Here we investigate the role
of the human leukocyte antigen (HLA) class I genes in this biological
process.
Methods & Materials: Three hundred patients with tubercu-
losis from South Africa were typed for their HLA class I alleles by
direct sequencing. Mycobacterium tuberculosis genotype classiﬁca-
tionwasdoneby IS6110 restriction fragment lengthpolymorphism
genotyping and spoligotyping.
Results: We showed that Beijing strain occurred more fre-
quently in individuals with multiple disease episodes (P < .001)
with the HLA-B27 allele lowering the odds of having an additional
episode (odds ratio, 0.21; P = .006). Associations were identiﬁed for
speciﬁc HLA types and disease caused by the Beijing, LAM, LCC,
and Quebec strains. HLA types were also associated with disease
caused by strains from the Euro-American or East Asian lineages,
and the frequencies of these alleles in their sympatric humanpopu-
lations identiﬁed potential coevolutionary events between host
and pathogen.
Conclusion: This is the ﬁrst report of the association of human
HLA types and Mycobacterium tuberculosis strain genotype, high-
lighting that both host and pathogen genetics need to be taken into
consideration when studying tuberculosis disease development.
http://dx.doi.org/10.1016/j.ijid.2014.03.1043
